SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds

GlobeNewswire
2025.10.27 13:38
portai
I'm PortAI, I can summarize articles.

NEW YORK, Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- SELLAS Life Sciences Group, Inc. ( NASDAQ: SLS ) ( "SELLAS" or the "Company" ) , a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced the immediate ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer